Skip to main content
OpenTrials
Completed

NCT Number: NCT07198399

Effects of Auri Super Mushroom Daily Gummies on Cognitive Health

This is a single-arm, open-label, virtual clinical trial evaluating the cognitive health effects of Auri Super Mushroom Daily Gummies in a population of 35 adult participants over 8 weeks. Participants will consume two gummies daily and complete validated cognitive testing and self-assessment questionnaires to assess changes in cognitive performance, energy, mood, memory, and overall well-being.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cognitive Decline Cognition Disorders Cognitive Dysfunction Focus Deficit Mental Disorders Neurocognitive Disorders

Age range

30 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89118, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be male or female
  • Be aged 30+
  • Anyone who has been experiencing issues consistently for the last four weeks regarding all of the following:

Forgetfulness Inability to focus Low energy levels Low mood

  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease
  • Willing to stop any other products or any medication or supplements that target cognition or cognitive health for the study duration
  • Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study
  • Not undergone any surgeries or invasive treatments in the last six months
  • Not had any major illness in the last three months
  • Resides in the United States
  • Not currently partaking in another research study and will not be partaking in any other research study for the next 8 weeks and at any point during this study's duration
  • Willing to consult with their healthcare provider before enrolling in the study if taking any prescription medication

Exclusion criteria

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone with any allergies or sensitivities to any of the study product ingredients
  • Anyone taking immunosuppressants
  • Anyone taking blood thinners (anticoagulants)
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
  • Anyone unwilling to follow the study protocol
  • Anyone with a history of substance abuse
  • Anyone with intolerance or sensitivity to mushrooms

Treatment and study plan

Auri Super Mushroom Daily Gummies

Dietary Supplement

Each gummy contains a blend of 12 functional mushroom extracts (300 mg equivalent each).

Primary outcomes

  1. Change in Cognitive Performance - Digit Span Test

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    The Digit Span test measures working memory capacity. Participants are presented with a series of numbers and asked to recall them in order.

    Performance is scored based on the total number of correctly recalled sequences.

    Scale Name: Digit Span Score Range: 0 to 14 Direction: Higher scores indicate better cognitive performance.

  2. Change in Cognitive Performance - Paired Associates Test

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8

    The Paired Associates task assesses memory by asking participants to recall which items were previously paired together.

    Score is based on the number of correct associations recalled.

    Scale Name: Paired Associates Score Range: 0 to 12 Direction: Higher scores indicate better cognitive performance.

  3. Change in Attention and Processing Speed - Double Trouble Task

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8

    Double Trouble is a Stroop-like task that measures attention control and response inhibition.

    Performance is measured by accuracy (%) and completion time (seconds).

    Scale Name: Double Trouble Accuracy (%) Range: 0 to 100 Direction: Higher percentage indicates better attention and cognitive control.

Secondary outcomes

  1. Self-Reported Focus - Questionnaire Score

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    Participants rate their ability to focus using a Likert-style scale.

    Scale Name: Focus Rating Scale (1-10) Range: 1 (poor focus) to 10 (excellent focus) Direction: Higher scores indicate better focus

  2. Self-Reported Memory - Questionnaire Score

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    Participants self-assess memory retention using a 10-point Likert scale.

    Scale Name: Memory Rating Scale (1-10) Range: 1 (poor memory) to 10 (excellent memory) Direction: Higher scores indicate better memory

Sponsors and collaborators

Lead sponsor

Auri Nutrition

Industry

Collaborators

  • Citruslabs

Registry information

Official study title

A Clinical Trial to Evaluate the Effects of a Supplement on Cognitive Health

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 30, 2025
Registry last updated
Sep 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.